Literature DB >> 32630560

Chemical, Physical and Biological Triggers of Evolutionary Conserved Bcl-xL-Mediated Apoptosis.

Aleksandr Ianevski1, Evgeny Kulesskiy2, Klara Krpina1, Guofeng Lou3, Yahyah Aman3, Andrii Bugai4, Koit Aasumets5, Yevhen Akimov2, Daria Bulanova2, Kiira Gildemann5, Albert F Arutyunyan6, Olga Yu Susova7, Alexei L Zhuze6, Ping Ji1, Wei Wang1, Toril Holien1,8, Marit Bugge1, Eva Zusinaite5, Valentyn Oksenych1, Hilde Lysvand1, Joachim M Gerhold5, Magnar Bjørås1, Pål Johansen9, Anders Waage1,8, Caroline A Heckman2, Evandro F Fang3, Denis E Kainov1,2,5.   

Abstract

BACKGROUND: The evidence that pan-Bcl-2 or Bcl-xL-specific inhibitors prematurely kill virus-infected or RNA/DNA-transfected cells provides rationale for investigating these apoptotic inducers further. We hypothesized that not only invasive RNA or DNA (biological factors) but also DNA/RNA-damaging chemical or physical factors could trigger apoptosis that have been sensitized with pan-Bcl-2 or Bcl-xL-specific agents;
Methods: We tested chemical and physical factors plus Bcl-xL-specific inhibitor A-1155463 in cells of various origins and the small roundworms (C. elegans);
Results: We show that combination of a A-1155463 along with a DNA-damaging agent, 4-nitroquinoline-1-oxide (4NQO), prematurely kills cells of various origins as well as C. elegans. The synergistic effect is p53-dependent and associated with the release of Bad and Bax from Bcl-xL, which trigger mitochondrial outer membrane permeabilization. Furthermore, we found that combining Bcl-xL-specific inhibitors with various chemical compounds or physical insults also induced cell death; Conclusions: Thus, we were able to identify several biological, chemical and physical triggers of the evolutionarily conserved Bcl-xL-mediated apoptotic pathway, shedding light on strategies and targets for novel drug development.

Entities:  

Keywords:  Bcl-xL; apoptosis; navitoclax; oncolytics

Year:  2020        PMID: 32630560     DOI: 10.3390/cancers12061694

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  5 in total

1.  DNA Damage Response.

Authors:  Valentyn Oksenych; Denis E Kainov
Journal:  Biomolecules       Date:  2021-01-19

2.  Synergistic Interferon-Alpha-Based Combinations for Treatment of SARS-CoV-2 and Other Viral Infections.

Authors:  Aleksandr Ianevski; Rouan Yao; Eva Zusinaite; Laura Sandra Lello; Sainan Wang; Eunji Jo; Jaewon Yang; Erlend Ravlo; Wei Wang; Hilde Lysvand; Kirsti Løseth; Valentyn Oksenych; Tanel Tenson; Marc P Windisch; Minna M Poranen; Anni I Nieminen; Svein Arne Nordbø; Mona Høysæter Fenstad; Gunnveig Grødeland; Pål Aukrust; Marius Trøseid; Anu Kantele; Eglė Lastauskienė; Astra Vitkauskienė; Nicolas Legrand; Andres Merits; Magnar Bjørås; Denis E Kainov
Journal:  Viruses       Date:  2021-12-11       Impact factor: 5.048

3.  Active Components of Commonly Prescribed Medicines Affect Influenza A Virus-Host Cell Interaction: A Pilot Study.

Authors:  Aleksandr Ianevski; Rouan Yao; Eva Zusinaite; Hilde Lysvand; Valentyn Oksenych; Tanel Tenson; Magnar Bjørås; Denis Kainov
Journal:  Viruses       Date:  2021-08-03       Impact factor: 5.048

Review 4.  Mono- and combinational drug therapies for global viral pandemic preparedness.

Authors:  Aleksandr Ianevski; Rouan Yao; Ronja M Simonsen; Vegard Myhre; Erlend Ravlo; Gerda D Kaynova; Eva Zusinaite; Judith M White; Stephen J Polyak; Valentyn Oksenych; Marc P Windisch; Qiuwei Pan; Eglė Lastauskienė; Astra Vitkauskienė; Algimantas Matukevičius; Tanel Tenson; Magnar Bjørås; Denis E Kainov
Journal:  iScience       Date:  2022-03-17

Review 5.  Interaction between Fibroblasts and Immune Cells Following DNA Damage Induced by Ionizing Radiation.

Authors:  Kalaiyarasi Ragunathan; Nikki Lyn Esnardo Upfold; Valentyn Oksenych
Journal:  Int J Mol Sci       Date:  2020-11-16       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.